blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3431092

EP3431092 - OPHTHALMIC SOLUTION COMPRISING DIQUAFOSOL [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.12.2019
Database last updated on 10.07.2024
FormerThe application has been published
Status updated on  21.12.2018
Most recent event   Tooltip13.12.2019Application deemed to be withdrawnpublished on 15.01.2020  [2020/03]
Applicant(s)For all designated states
Santen Pharmaceutical Co., Ltd.
9-19, Shimoshinjo 3-chome
Higashiyodogawa-ku
Osaka-shi
Osaka 533-8651 / JP
[2019/04]
Inventor(s)01 / SAKATANI, Akiko
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
02 / IKEI, Tatsuo
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
03 / INAGAKI, Koji
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
04 / NAKAMURA, Masatsugu
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
05 / HOSOI, Kazuhiro
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
06 / SAITO, Mikiko
c/o SANTEN PHARMACEUTICAL CO., LTD.
8916-16 Takayama-cho
Ikoma-shi
Nara, 630-0101 / JP
07 / SONODA, Masaki
c/o SANTEN PHARMACEUTICAL CO., LTD.
9-19 Shimoshinjo 3-chome
Higashiyodogawa-ku
Osaka-shi
Osaka, 533-8651 / JP
08 / FUKUI, Yoko
c/o SANTEN PHARMACEUTICAL CO., LTD.
9-19 Shimoshinjo 3-chome
Higashiyodogawa-ku
Osaka-shi
Osaka, 533-8651 / JP
09 / KUWANO, Mitsuaki
c/o SANTEN PHARMACEUTICAL CO., LTD.
9-19 Shimoshinjo 3-chome
Higashiyodogawa-ku
Osaka-shi
Osaka, 533-8651 / JP
 [2019/04]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2019/04]
Application number, filing date18193430.825.03.2013
[2019/04]
Priority number, dateJP2012006915726.03.2012         Original published format: JP 2012069157
[2019/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3431092
Date:23.01.2019
Language:EN
[2019/04]
Search report(s)(Supplementary) European search report - dispatched on:EP17.10.2018
ClassificationIPC:A61K31/7084, A61K9/08, A61K47/04, A61K47/12, A61K47/24, A61P27/02
[2019/04]
CPC:
A61K31/7084 (EP,KR,US); A61K9/08 (KR); A61K47/12 (EP,KR,US);
A61K47/183 (EP,US); A61K47/24 (EP,US); A61K9/0048 (EP,US);
A61P27/02 (EP); A61P27/04 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
TitleGerman:OPHTHALMISCHE LÖSUNG MIT DIQUAFLOSOL[2019/04]
English:OPHTHALMIC SOLUTION COMPRISING DIQUAFOSOL[2019/04]
French:SOLUTION OPHTALMIQUE COMPRENANT DU DIQUAFOSOL[2019/04]
Examination procedure24.07.2019Application deemed to be withdrawn, date of legal effect  [2020/03]
21.08.2019Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2020/03]
Parent application(s)   TooltipEP13770386.4  / EP2832359
Fees paidRenewal fee
10.09.2018Renewal fee patent year 03
10.09.2018Renewal fee patent year 04
10.09.2018Renewal fee patent year 05
10.09.2018Renewal fee patent year 06
26.03.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]JP2003160491  (SANTEN PHARMACEUTICAL CO LTD ) [X] 1-3,6,7,9,10 * paragraphs [0018] , [0 23] , [0 25] *;
 [XP]WO2012090994  (SANTEN PHARMACEUTICAL CO LTD [JP], et al) [XP] 1-4,6,15* claims 1-12 *;
 [A]  - KELLY K NICHOLS ET AL, "Diquafosol tetrasodium: a novel dry eye therapy", EXPERT OPINION ON INVESTIGATIONAL DRUGS, (20040101), vol. 13, no. 1, doi:10.1517/eoid.13.1.47.25281, ISSN 1354-3784, pages 47 - 54, XP055148404 [A] 1-15 * paragraph [06.2] *

DOI:   http://dx.doi.org/10.1517/eoid.13.1.47.25281
by applicantJP2001510484
 JP3652707B
 JP2007182438
    - Cornea, (20040000), vol. 23, no. 8, pages 784 - 792
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.